Abstract
We tested 59 common and 27 uncommon Aspergillus species isolates for the susceptibility to the mold-active azole antifungal agents, itraconazole, voriconazole, and posaconazole, using the Sensititre method. The overall essential agreement with the CLSI reference method was 96.5% for itraconazole and posaconazole, and 100% for voriconazole. By Sensititre, as well as CLSI, all of 10 A. fumigatus isolates with a cyp51 mutant genotype were classified as being non-wild-type (MIC > ECV) to triazoles.
Lingua originale | English |
---|---|
pagine (da-a) | 00168-17-N/A |
Rivista | Antimicrobial Agents and Chemotherapy |
Volume | 61 |
DOI | |
Stato di pubblicazione | Pubblicato - 2017 |
Keywords
- Aspergillus